Objective The negative effects of glucocorticoids on bone depend on dose and treatment
duration. However, it is unclear whether a safe dose exists, especially for patients with …

Objectives Clinical trials have shown that low-dose glucocorticoid therapy in patients with
RA reduces bone loss in hands or hip, but the effect on osteoporotic fractures is not yet clear …

Background It is unclear whether sex or age modify the association of glucocorticoid (GC)
use with reduced bone mineral density (BMD) in patients with rheumatoid arthritis (RA) …

Objective. To identify the effects of glucocorticoids (GC) on various types of fractures in
patients with rheumatoid arthritis (RA). Methods. We used the Korean National Healthcare …

We evaluated the effects of glucocorticoids on bone mineral density (BMD), and prevalence
of osteoporosis and fracture in rheumatoid arthritis (RA) by meta-analysis. Until June 26 …

Introduction Glucocorticoid (GC)-induced osteoporosis is a frequent complication in patients
with rheumatoid arthritis. However, little information exists about the consequences of GC …

Retrospective claims analysis indicated that high levels of daily and cumulative doses of
systemic glucocorticoids were associated with elevated fracture risk in a large cohort of new …

Rheumatologic diseases are associated with a proinflammatory state, which is thought to
lead to many of the bone changes seen in treatment-naive patients. However …

This study aimed to investigate the effect of low-dose glucocorticoids (LDGs) on disease
activity, bone density, and fractures in patients with rheumatoid arthritis (RA). This was an …

Glucocorticoids, prescribed for their antiinflammatory and immunosuppressive features, are
the most common cause of secondary osteoporosis. Used to treat a variety of diseases …